Inventor · disambiguated record
Katie Streicher
Also filed as: STREICHER KATIE
5 granted patents·13 pending applications·5 citations·filing 2011–2024
69Inventor score
Top patents by PatentIndex Score
18 records- 0181US11016099B2Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkersAMGEN INC·Filed 2016·Granted May 25, 2021·3 cites·22 claims
- 0277US11220541B2CCL20 as a predictor of clinical response to IL23-antagonistsAMGEN INC·Filed 2016·Granted Jan 11, 2022·1 cites·32 claims
- 0371US2025019408A1Cd40l antagonist and uses thereofVIELA BIO INC·Filed 2024·Application pending·0 cites
- 0470US10775388B2Methods of using antibodies to determine periostin levels in a sampleMEDIMMUNE LLC·Filed 2015·Granted Sep 15, 2020·1 cites·23 claims
- 0563US2022144935A1Ccl20 as a predictor of clinical response to il23-antagonistsAMGEN INC·Filed 2021·Application pending·0 cites
- 0658US2021340200A1Cd40l antagonist and uses thereofVIELA BIO INC·Filed 2019·Application pending·0 cites
- 0757US2025002589A1Treatment of cutaneous lupus erythematousASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0855US9862762B2Monoclonal antibodies which bind human periostinMEDIMMUNE LLC·Filed 2015·Granted Jan 9, 2018·0 cites·18 claims
- 0955US2018179272A1Novel assay to detect human periostinMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 1053US2022373539A1Prediction of clinical response to il23-antagonists using il23 pathway biomarkersAMGEN INC·Filed 2021·Application pending·0 cites
- 1152US10006026B2Recombinant polypeptide productionMEDIMMUNE LLC·Filed 2014·Granted Jun 26, 2018·0 cites·20 claims
- 1248US2015252431A1Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapyMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 1348US2017088628A1Compositions and Methods for Identifying B Cell Malignancies Responsive to B Cell Depleting TherapyMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 1439US2017275347A1Methods for identifying patients responsive to anti-pd-l1 antibody therapyMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
- 1538US2013108646A1Optimized degenerative muscle disease diagnostics and treatmentsYAO YIHONG·Filed 2011·Application pending·0 cites
- 1638US2018079814A1Combined anti-pld-1 and anti-ctla-4 antibodies for treating non-small lung cancerMEDIMMUNE LTD·Filed 2016·Application pending·0 cites
- 1736US2014045924A1Melanoma treatmentsYAO YIHONG·Filed 2011·Application pending·0 cites
- 1831US2016363591A1Dipeptidyl peptidase-4 (dpp4/cd26) as a peripheral biomarker of il-13 activation in asthmatic lungMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katie Streicher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →